Form 4: Roivant Sciences President & COO Eric Venker Reports Changes in Beneficial Ownership
SEC Form 4 Filing
Eric Venker, President & COO of Roivant Sciences Ltd., reports a transaction involving common shares to cover tax obligations related to vested RSUs.
Summary
- On July 20, 2024, Eric Venker, the President & COO of Roivant Sciences Ltd., engaged in a transaction involving the disposition of 10,945 common shares.
- This transaction was executed to cover tax withholding obligations related to the vesting and settlement of previously granted Restricted Stock Units (RSUs).
- The shares were disposed of at a price of $11.
- Following the transaction, Venker directly owns 446,307 common shares.
Sentiment
Score: 5
Explanation: The document reflects a routine transaction related to executive compensation and tax obligations, with no inherent positive or negative implications for the company's overall outlook.
Industry Context
Form 4 filings are a routine part of insider trading regulations, providing transparency into the transactions of company executives and directors. This filing indicates a standard practice of covering tax obligations related to RSU vesting.
Key Dates
| Date | Description |
|---|---|
| 07/20/2024 | Date of transaction involving the disposition of common shares. |
| 07/25/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.